drugset / Trial / NCT00363870

A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults

NCT00363870

Phase 4 Completed 7632 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to demonstrate the efficacy of GSK Biologicals' influenza vaccine (Fluarix™) administered intramuscularly in adults.

Timeline

Start
2006-09
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine Intramuscular

Indications